Funding Rounds
Thioredoxin Systems

Thioredoxin Systems Series A Round, October 2024

Thioredoxin Systems

Developer of a first-in-class antibiotic for multidrug-resistant urinary tract infections

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $2.40M

Raised Date: 2024-10-30